Aclaris Therapeutics (ACRS) Change in Inventory (2018 - 2019)

Aclaris Therapeutics' (ACRS) quarterly Change in Inventory came in at -$3000.0 in Q4 2019, up 99.74% year-on-year from -$1502.0 in Q4 2018, and down 175.0% quarter-over-quarter from $4000.0 in Q3 2019.

Aclaris Therapeutics (ACRS) Change in Inventory (2018 - 2019) Analysis & Trends

Aclaris Therapeutics' Change in Inventory history runs 2 years deep, the most recent figure standing at -$3000.0 for Q4 2019.

  • On a quarterly basis, Change in Inventory rose 99.74% year-over-year to -$3000.0 in Q4 2019; TTM through Dec 2019 was -$605000.0, a N/A change from a year earlier, with the FY2019 full-year figure at -$605000.0, down 493.14% from the prior year.
  • Change in Inventory fell to -$3000.0 in Q4 2019 per ACRS's latest filing, from $4000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $65000.0 in Q1 2019 and bottomed at -$1.1 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 71.84 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Aclaris Therapeutics 687.20 Mn 581.79 Mn 1.60 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 -3,000.00
Dec 31, 2019 -3,000.00
Sep 30, 2019 4,000.00
Sep 30, 2019 4,000.00
Jun 30, 2019 -671,000.00
Jun 30, 2019 -671,000.00
Mar 31, 2019 65,000.00
Mar 31, 2019 65,000.00
Dec 31, 2018 -1.15 Mn
Dec 31, 2018 -1.15 Mn
Sep 30, 2018 18,000.00
Sep 30, 2018 18,000.00